Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications

View ORCID ProfileJesse Huang
doi: https://doi.org/10.1101/2020.10.02.20205609
Jesse Huang
1Kii Research Institute, Vancouver, Washington, USA
2Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesse Huang
  • For correspondence: jesse.huang@ki.se
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Severe coronavirus disease 2019 (COVID-19) has been associated with certain preexisting health conditions and can cause respiratory failure along with other multi-organ injuries. However, the mechanism of these relationships is unclear, and prognostic biomarkers for the disease and its systemic complications are lacking. This study aims to examine the plasma protein profile of COVID-19 patients and evaluate overlapping protein modules with biomarkers of common comorbidities.

Blood samples were collected from COVID-19 cases (n=307) and negative controls (n=78) among patients with acute respiratory distress. Proteins were measured by proximity extension assay utilizing next-generation sequencing technology. Its associations to COVID-19 disease characteristics were compared to that of preexisting conditions and established biomarkers for myocardial infarction (MI), stroke, hypertension, diabetes, smoking, and chronic kidney disease.

Several proteins were differentially expressed in COVID-19, including multiple pro-inflammatory cytokines such as IFN-γ, CXCL10, and CCL7/MCP-3. Elevated IL-6 was associated with increased severity, while baseline IL1RL1/ST2 levels were associated with a worse prognosis. Network analysis identified several protein modules associated with COVID-19 disease characteristics overlapping with processes of preexisting hypertension and impaired kidney function. BNP and NTpro-BNP, markers for MI and stroke, increased with disease progression and were positively associated with severity. MMP12 was similarly elevated and has been previously linked to smoking and inflammation in emphysema, along with increased cardiovascular disease risk.

In conclusion, this study provides an overview of the systemic effects of COVID-19 and candidate biomarkers for clinical assessment of disease progression and the risk of systemic complications.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Study data was provide by Massachusetts General Hospitalm (MGH) in collaboration with Olink Proteomics.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study was approved and conducted at the Massachusetts General Hospital, and resulting data have already been made publicly available by request.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Study data is available for request as of October 2, 2020.

https://info.olink.com/mgh-covid-study-overview-page

  • Abbreviations

    ACE2
    Angiotensin-converting enzyme 2
    ARDS
    Acute respiratory distress syndrome
    BMI
    Body mass index
    CVD
    Cardiovascular-related death
    CKD
    Chronic kidney disease
    COVID-19
    Coronavirus disease 2019
    eGFR
    Estimated glomerular filtration rate
    HF
    Heart failure
    IL-6
    Interleukin-6
    IL1RL1/ST2
    Interleukin 1 receptor-like 1
    LEP
    Leptin
    MERS
    Middle Eastern respiratory syndrome
    MI
    Myocardial infarction
    NGS
    Next-generation sequencing
    NPPB/BNP
    B-type natriuretic peptide
    NPX
    Normalized protein expression
    NT-proBNP
    N-terminal pro–B-type natriuretic peptide
    PEA
    Proximity extension assay
    SARS
    Severe acute respiratory syndrome
    SARS-CoV2
    Severe acute respiratory syndrome coronavirus 2
    WGCNA
    Weighted gene correlation network analysis
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 05, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
    Jesse Huang
    medRxiv 2020.10.02.20205609; doi: https://doi.org/10.1101/2020.10.02.20205609
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
    Jesse Huang
    medRxiv 2020.10.02.20205609; doi: https://doi.org/10.1101/2020.10.02.20205609

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (214)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1091)
    • Dentistry and Oral Medicine (194)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
    • Epidemiology (9747)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2299)
    • Geriatric Medicine (221)
    • Health Economics (461)
    • Health Informatics (1548)
    • Health Policy (729)
    • Health Systems and Quality Improvement (600)
    • Hematology (236)
    • HIV/AIDS (500)
    • Infectious Diseases (except HIV/AIDS) (11623)
    • Intensive Care and Critical Care Medicine (615)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (256)
    • Neurology (2137)
    • Nursing (133)
    • Nutrition (332)
    • Obstetrics and Gynecology (424)
    • Occupational and Environmental Health (516)
    • Oncology (1171)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (308)
    • Pediatrics (693)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2168)
    • Public and Global Health (4640)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (451)
    • Respiratory Medicine (622)
    • Rheumatology (273)
    • Sexual and Reproductive Health (224)
    • Sports Medicine (208)
    • Surgery (250)
    • Toxicology (42)
    • Transplantation (120)
    • Urology (94)